MedTrace Logo

Pilot Study to Evaluate the Effect of ENI Patented Whole Grape Extract on Antioxidant Status

NCT01551706 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2012-07-04

No results posted yet for this study

Summary

This is a Randomized, Double-blind, Placebo-controlled, Pilot Study to Evaluate the Effect of ENI Patented Whole Grape Extract on Antioxidant Status.

Conditions

  • High Oxidation Stress
  • Oxidized LDL Level

Interventions

DIETARY_SUPPLEMENT

ENI Patented Whole Grape Extract

ENI Patented Whole Grape Extract

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Ethical Naturals, Inc.

    lead OTHER

Principal Investigators

  • Dale Wilson · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-04-30
Completion
2012-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01551706 on ClinicalTrials.gov